Renal Anemia of Inflammation: The Name Is Self-Explanatory

Statin therapy reduces inflammatory markers in hypercholesterolemic patients with high baseline levels

(2011) Yuki Horiuchi et al.   Journal of Atherosclerosis and Thrombosis

In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2

(2010) K. Maes et al.   BLOOD

Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease

(2010) S.-N. J. Song et al.   BLOOD

Erythropoietin prevents vascular inflammation and oxidative stress in subtotal nephrectomized rat aorta beyond haematopoiesis

(2010) Hiroe Toba et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

What is causing the mortality in treating the anemia of chronic kidney disease: erythropoietin dose or hemoglobin level?

(2010) Ajay K Singh   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Erythropoietin regulates intestinal iron absorption in a rat model of chronic renal failure

(2010) Surjit K. Srai et al.   KIDNEY INTERNATIONAL

Prevalence of Anemia and Its Impact on Mortality and Hospitalization Rate in Predialysis Patients

(2010) N. Voormolen et al.   NEPHRON CLINICAL PRACTICE

Effect of Recombinant Human Erythropoietin on Serum S100B Protein and Interleukin-6 Levels After Traumatic Brain Injury in the Rat

(2010) Xiao-xing BIAN et al.   NEUROLOGIA MEDICO-CHIRURGICA

Recombinant Human Erythropoietin Pretreatment Attenuates Heart Ischemia-Reperfusion Injury in Rats by Suppressing the Systemic Inflammatory Response

(2010) Y. Shen et al.   TRANSPLANTATION PROCEEDINGS

High serum levels of TNF-α and IL-6 predict the clinical outcome of treatment with human recombinant erythropoietin in anaemic cancer patients

(2009) I. Pavese et al.   ANNALS OF ONCOLOGY

Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli

(2009) H. Huang et al.   BLOOD

Erythropoiesis Stimulatory Agent- Resistant Anemia in Dialysis Patients: Review of Causes and Management

(2009) Mehmet Kanbay et al.   BLOOD PURIFICATION

Hepcidin--A Potential Novel Biomarker for Iron Status in Chronic Kidney Disease

(2009) J. Zaritsky et al.   Clinical Journal of the American Society of Nephrology

Iron in innate immunity: starve the invaders

(2009) Tomas Ganz   CURRENT OPINION IN IMMUNOLOGY

Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin

(2009) D. R. Ashby et al.   HAEMATOLOGICA

Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease

(2009) Damien R. Ashby et al.   KIDNEY INTERNATIONAL

Pentoxifylline improves haemoglobin and interleukin-6 levels in chronic kidney disease

(2009) PAOLO FERRARI et al.   NEPHROLOGY

Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LC-MS/MS

(2009) Hongyan Li et al.   JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS

Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBP 

(2008) J. P. Pinto et al.   BLOOD

Anemia of chronic disease: A harmful disorder or an adaptive, beneficial response?

(2008) R. Zarychanski et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Effect of fluvastatin on serum prohepcidin levels in patients with end-stage renal disease

(2008) Mahmut Arabul et al.   CLINICAL BIOCHEMISTRY

Effect of erythropoietin on hepcidin, DMT1 with IRE, and hephaestin gene expression in duodenum of rats

(2008) Wei-Na Kong et al.   JOURNAL OF GASTROENTEROLOGY

Anemia of Critical Illness

(2008) Kwame Asare   PHARMACOTHERAPY

Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: a randomized controlled trial

(2008) David Wayne Johnson et al.   BMC Nephrology